This course will offer a unique combination of multidisciplinary management of complex skin cancers with an update on clinically relevant issues in pathology. Novel diagnostic methods and updates in tumor classification will be emphasized. Melanoma and other complex skin malignancies will be presented and discussed in a tumor board style with a panel of experts from dermatology, head and neck surgery, medical, surgical, and ophthalmic oncology, pathology, and radiation oncology.

The target audience includes physicians and allied health professionals, who care for patients with skin cancer, including dermatologists, surgical and medical oncologists, otolaryngologists, ophthalmologists, general surgeons, plastic surgeons, pathologists and radiation oncologists.

1. Describe melanoma and non melanoma skin cancer incidence and staging systems
2. Assess role of ancillary tests for melanoma diagnosis and prognosis
3. Review recent updates in WHO classification of melanocytic tumors
4. Define characteristics of skin cancers that require multidisciplinary treatment
5. Review novel approaches to optimize surgical treatment of skin cancers
6. Assess role and variety of radiotherapeutic approaches to complex skin cancer
7. Review role of biological therapy in the treatment of advanced skin cancer

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. Visit our Help page for more information.

By registering for the live virtual course, you will be able to view presentations, hear live audio, and interact online. CME credit will be offered for this course and a certificate will be available after a post-course evaluation is complete. This new live virtual course will be fully web-based, so all you will need is a computer, phone, or tablet and an internet connection. Access details will be emailed to all attendees before the course.

MSK CME is closely monitoring the evolving situation and if in-person attendance for this course becomes available, attendees will have the option to switch registration from virtual to in-person. If you are interested in receiving updates about in-person attendance for this course, please be sure to select this option during registration. 

Registration Discounts/Promotions

• MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact cme@mskcc.org for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email cme@mskcc.org.

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $25 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

If it has been more than 120 days since you paid for a course, or submitted a check for payment, a W9 form will need to be completed for us to refund your registration. You will not be taxed on your refund.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MSK Course Directors 

Kishwer S. Nehal, MD
Director, Mohs Micrographic and Dermatologic Surgery
Program Director, Micrographic Surgery and Dermatologic Oncology Fellowship
Attending Physician
Dermatology Service
Department of Medicine

Bhuvanesh Singh, MD, PhD
Director, Laboratory of Epithelial Cancer Biology
Attending Surgeon
Head & Neck Service
Department of Surgery

Klaus J. Busam, MD
Director, Dermatopathology Service
Director, Dermatopathology Fellowship Program
Attending Pathologist
Surgical Pathology Service
Department of Pathology

Invited Course Faculty 

Susan M. Swetter, MD
Professor of Dermatology
Director, Pigmented Lesion and Melanoma Program
Physician Leader, Cancer Care Program in Cutaneous Oncology
Stanford University Medical Center and Cancer Institute

Michael T. Tetzlaff, MD, PhD
Associate Professor
Departments of Pathology and Translational and Molecular Pathology
University of Texas MD Anderson Cancer Center

Iwei Yeh, MD, PhD
Associate Professor of Dermatology and Pathology
University of California San Francisco (UCSF)
Associate Director, UCSF Clinical Cancer Genomics Laboratory

MSK Course Faculty 

Faculty Disclosures (All Faculty)